Clinical Trial Update: Oculomotor Testing in the Differential Diagnosis of Dementia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oculomotor testing to differentiate dementia with Lewy bodies from Alzheimer's disease; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia with Lewy Bodies

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Lewy Body Disease, Alzheimer's Disease | Phase 3 | Status: COMPLETED